# Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)

> **NCT00824746** · PHASE2 · COMPLETED · sponsor: **Chonnam National University Hospital** · enrollment: 23 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Gefitinib retreatment

## Key facts

- **NCT ID:** NCT00824746
- **Lead sponsor:** Chonnam National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-06
- **Final completion:** 2011-12
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2013-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00824746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00824746, "Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00824746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*